Duolingo's stock jumps 6% on news it is joining S&P MidCap 400
By Jon Swartz
Duolingo Inc.'s stock popped 6% in extended trading Wednesday following news it is joining the S&P MidCap 400.
As part of the corporate reshuffling, Duolingo (DUOL) will replace Cable One Inc. (CABO), which, in turn, will supplant MDC Holdings Inc. (MDC) in the S&P SmallCap 600. The moves are effective April 22, S&P Global said on Wednesday.
Sekisui House Ltd. (JP:1928) is acquiring MDC Holdings in a transaction expected to be completed on April 19, pending final conditions.
Duolingo offers courses on music, math and more than 40 languages, including English, French and Spanish.
Earlier this month, spinoffs GE Vernova Inc. (GEV) and Solventum Corp. (SOLV) joined the S&P 500 index SPX.
GE Vernova is a renewable-power-generation company that resulted from the split of General Electric Co. into GE Aerospace (GE) and GE Vernova. Solventum was splintered from 3M's (MMM) healthcare business.
-Jon Swartz
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
04-17-24 1818ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Amazon Earnings: AWS Growth Accelerates and Profit Margins Improve
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?